Azmacort and Ceftazidime drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azmacort (triamcinolone acetonide) and Ceftazidime (ceftazidime). Common drug interactions include anaemia among females and septic shock among males.

The phase IV clinical study analyzes what interactions people have when they take Azmacort and Ceftazidime. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Azmacort?

Azmacort has active ingredients of triamcinolone acetonide. It is often used in asthma. eHealthMe is studying from 3,612 Azmacort users. Check the latest studies of Azmacort.

What is Ceftazidime?

Ceftazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,327 Ceftazidime users. Check the latest studies of Ceftazidime.

On Jul, 15, 2026

11 people who take Azmacort and Ceftazidime together, and have interactions are studied.

Azmacort and Ceftazidime drug interactions.

What are the common drug interactions of Azmacort and Ceftazidime, by gender? *:

female:

Anaemia (lack of blood)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Chest pain
Churg strauss syndrome (infection of small arteries and vein)
Dyspnoea (difficult or laboured respiration)
Hypokalaemia (low potassium)
Infection
Ovarian neoplasm (tumour of ovary)
Pericardial effusion (fluid around the heart)
Pericarditis (inflammation of the pericardium)

male:

Septic shock (shock due to blood infection)
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Renal tubular necrosis (death of kidney tubules)
Status asthmaticus (a asthma attack not responds to regular medicines)
Drug ineffective
Duodenal ulcer haemorrhage (bleeding duodenal ulcer)
Peritoneal haemorrhage (peritoneal bleeding)
Pulmonary haemorrhage (acute bleeding from the lung)
Retroperitoneal haemorrhage (bleeding between the peritoneum and the posterior abdominal wall)
Drug intolerance (drug sensitivity)

What are the common drug interactions of Azmacort and Ceftazidime, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Disseminated intravascular coagulation (systemic activation of blood coagulation)
Respiratory failure (inadequate gas exchange by the respiratory system)
Septic shock (shock due to blood infection)
Cardiogenic shock (inadequate circulation of blood)
Gastrointestinal necrosis (destruction of gastrointestinal organ)
Hepatic failure (liver failure)
Hypotension (abnormally low blood pressure)
Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
Lactic acidosis (low ph in body tissues)
Renal failure (kidney dysfunction)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Anaemia (lack of blood)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Pleuritic pain
Pulmonary embolism (blockage of the main artery of the lung)
Rigors (an episode of shaking or exaggerated shivering)
Sinusitis chronic (long lasting infection of sinus)
Sweating increased (excess sweating)
Weakness
Chest pain
Churg strauss syndrome (infection of small arteries and vein)

60+:

n/a

What are the existing conditions these people have? *

Fever: 6 people, 54.55%
Sinusitis (inflammation of sinus): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Azmacort and Ceftazidime?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously